@inbook{c6df20e186c0443786e52e5d5d952cce,
title = "Adjuvant Therapy",
author = "{Sandoval Leon}, {Ana Cristina} and Reshma Mahtani and Mohammad Jahanzeb",
note = "Therapies for HER2-positive breast cancer have dramatically improved outcomes for this once dismal disease. Trastuzumab revolutionized the management of HER2-positive breast cancer and its discovery led to the development of other very effective HER2-targeted therapies. The optimal length of therapy as well as the sequential and concurrent use of trastuzumab with chemotherapy has been studied.",
year = "2019",
language = "American English",
booktitle = "Her2-Positive Breast Cancer",
}